Company Info
Cardiol Therapeutics Inc. is a clinical-stage biotechnology company focused on the research and development of anti-inflammatory and anti-fibrotic therapies for cardiovascular diseases. Based in Canada, the company specializes in leveraging cannabidiol (CBD) formulations to address conditions such as acute myocarditis, recurrent pericarditis, and heart failure. Cardiol’s lead product, CardiolRx™, is an ultra-pure, pharmaceutical-grade CBD under investigation for its potential to improve outcomes in heart-related disorders. The company is committed to advancing clinical trials and developing innovative therapies to meet significant unmet medical needs in cardiology.
Company Website